Kamada N
Immunology. 1985 Jul;55(3):369-89.
In many species, the rejection of liver allografts is milder than that of other organs. This is especially so in the rat where, without immunosuppressive treatment, liver grafts between certain strain combinations are accepted permanently, whereas skin, heart and renal allografts undergo acute rejection. Reliable surgical methods, together with the availability of inbred strains and a rapidly developing knowledge of its MHC and immune system in general, have made the rat a prime species in which to study the immunological events which follow liver grafting. In non-rejector combinations, liver allografts possess remarkable properties of tolerance induction and antigen-specific immunosuppression, leading to a state of donor-specific unresponsiveness in which grafts of other organs are also accepted. Moreover, liver transplantation can terminate ongoing rejection reactions in other organs and convert an existing state of sensitization against donor antigens into one of unresponsiveness. This review describes recent progress in understanding the immunological mechanisms behind these phenomena. The topics discussed include the rat MHC (RT1) antigens and their distribution in the liver; the genetic control of rejection and non-rejection, including the role of MHC-linked immune response genes; and cellular and humoral mechanisms involved in tolerance and immunosuppression, such as clonal deletion of alloreactive lymphocytes and antibody-mediated enhancement.
在许多物种中,肝移植排斥反应比其他器官的排斥反应更为轻微。在大鼠中尤其如此,在没有免疫抑制治疗的情况下,某些品系组合之间的肝移植能够被永久接受,而皮肤、心脏和肾移植则会发生急性排斥反应。可靠的手术方法,加上近交系的可获得性以及对其主要组织相容性复合体(MHC)和整体免疫系统的快速发展的认识,使得大鼠成为研究肝移植后免疫事件的主要物种。在非排斥组合中,肝移植具有显著的耐受诱导和抗原特异性免疫抑制特性,导致产生供体特异性无反应状态,在此状态下其他器官的移植也能被接受。此外,肝移植可以终止其他器官正在进行的排斥反应,并将现有的针对供体抗原的致敏状态转变为无反应状态。这篇综述描述了在理解这些现象背后的免疫机制方面的最新进展。讨论的主题包括大鼠MHC(RT1)抗原及其在肝脏中的分布;排斥和非排斥的遗传控制,包括与MHC相关的免疫反应基因的作用;以及参与耐受和免疫抑制的细胞和体液机制,如同种反应性淋巴细胞的克隆清除和抗体介导的增强作用。